Depreciation of PHIBRO ANIMAL HEALTH CORP from 30 Jun 2012 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
PHIBRO ANIMAL HEALTH CORP quarterly and annual Depreciation in USD history and change rate from 30 Jun 2012 to 31 Dec 2025.
  • PHIBRO ANIMAL HEALTH CORP Depreciation for the quarter ending 31 Dec 2025 was $11,178,000, a 19% increase year-over-year.
  • PHIBRO ANIMAL HEALTH CORP Depreciation for the twelve months ending 31 Dec 2025 was $43,910,000, a 47% increase year-over-year.
  • PHIBRO ANIMAL HEALTH CORP annual Depreciation for 2025 was $37,762,000, a 42% increase from 2024.
  • PHIBRO ANIMAL HEALTH CORP annual Depreciation for 2024 was $26,517,000, a 9.1% increase from 2023.
  • PHIBRO ANIMAL HEALTH CORP annual Depreciation for 2023 was $24,316,000, a 2.2% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

PHIBRO ANIMAL HEALTH CORP Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $43,910,000 $11,178,000 +$1,769,000 +19% 01 Oct 2025 31 Dec 2025 10-Q 04 Feb 2026 2026 Q2
Q3 2025 $42,141,000 $11,121,000 +$4,379,000 +65% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2026 Q1
Q2 2025 $37,762,000 $10,714,000 +$3,835,000 +56% 01 Apr 2025 30 Jun 2025 10-K 27 Aug 2025 2025 FY
Q1 2025 $33,927,000 $10,897,000 +$4,127,000 +61% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q3
Q4 2024 $29,800,000 $9,409,000 +$2,972,000 +46% 01 Oct 2024 31 Dec 2024 10-Q 04 Feb 2026 2026 Q2
Q3 2024 $26,828,000 $6,742,000 +$311,000 +4.8% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2026 Q1
Q2 2024 $26,517,000 $6,879,000 +$740,000 +12% 01 Apr 2024 30 Jun 2024 10-K 27 Aug 2025 2025 FY
Q1 2024 $25,777,000 $6,770,000 +$703,000 +12% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q3
Q4 2023 $25,074,000 $6,437,000 +$378,000 +6.2% 01 Oct 2023 31 Dec 2023 10-Q 05 Feb 2025 2025 Q2
Q3 2023 $24,696,000 $6,431,000 +$380,000 +6.3% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024 2025 Q1
Q2 2023 $24,316,000 $6,139,000 +$150,000 +2.5% 01 Apr 2023 30 Jun 2023 10-K 27 Aug 2025 2025 FY
Q1 2023 $24,166,000 $6,067,000 -$147,000 -2.4% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q3
Q4 2022 $24,313,000 $6,059,000 +$195,000 +3.3% 01 Oct 2022 31 Dec 2022 10-Q 07 Feb 2024 2024 Q2
Q3 2022 $24,118,000 $6,051,000 +$337,000 +5.9% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2024 Q1
Q2 2022 $23,781,000 $5,989,000 +$303,000 +5.3% 01 Apr 2022 30 Jun 2022 10-K 28 Aug 2024 2024 FY
Q1 2022 $23,478,000 $6,214,000 +$451,000 +7.8% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023 2023 Q3
Q4 2021 $23,027,000 $5,864,000 -$21,000 -0.36% 01 Oct 2021 31 Dec 2021 10-Q 08 Feb 2023 2023 Q2
Q3 2021 $23,048,000 $5,714,000 -$117,000 -2% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2023 Q1
Q2 2021 $23,165,000 $5,686,000 -$169,000 -2.9% 01 Apr 2021 30 Jun 2021 10-K 30 Aug 2023 2023 FY
Q1 2021 $23,334,000 $5,763,000 -$61,000 -1% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q3
Q4 2020 $23,395,000 $5,885,000 +$45,000 +0.77% 01 Oct 2020 31 Dec 2020 10-Q 09 Feb 2022 2022 Q2
Q3 2020 $23,350,000 $5,831,000 +$100,000 +1.7% 01 Jul 2020 30 Sep 2020 10-Q 02 Nov 2021 2022 Q1
Q2 2020 $23,250,000 $5,855,000 +$252,000 +4.5% 01 Apr 2020 30 Jun 2020 10-K 24 Aug 2022 2022 FY
Q1 2020 $22,998,000 $5,824,000 +$500,000 +9.4% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q3
Q4 2019 $22,498,000 $5,840,000 +$532,000 +10% 01 Oct 2019 31 Dec 2019 10-Q 03 Feb 2021 2021 Q2
Q3 2019 $21,966,000 $5,731,000 +$543,000 +10% 01 Jul 2019 30 Sep 2019 10-Q 04 Nov 2020 2021 Q1
Q2 2019 $21,423,000 $5,603,000 +$225,000 +4.2% 01 Apr 2019 30 Jun 2019 10-K 25 Aug 2021 2021 FY
Q1 2019 $21,198,000 $5,324,000 +$63,000 +1.2% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q3
Q4 2018 $21,135,000 $5,308,000 +$86,000 +1.6% 01 Oct 2018 31 Dec 2018 10-Q 03 Feb 2020 2020 Q2
Q3 2018 $21,049,000 $5,188,000 +$5,000 +0.1% 01 Jul 2018 30 Sep 2018 10-Q 04 Nov 2019 2020 Q1
Q2 2018 $21,044,000 $5,378,000 +$545,000 +11% 01 Apr 2018 30 Jun 2018 10-K 26 Aug 2020 2020 FY
Q1 2018 $20,499,000 $5,261,000 -$139,000 -2.6% 01 Jan 2018 31 Mar 2018 10-Q 06 May 2019 2019 Q3
Q4 2017 $20,638,000 $5,222,000 +$270,000 +5.5% 01 Oct 2017 31 Dec 2017 10-Q 06 Feb 2019 2019 Q2
Q3 2017 $20,368,000 $5,183,000 +$452,000 +9.6% 01 Jul 2017 30 Sep 2017 10-Q 06 Nov 2018 2019 Q1
Q2 2017 $19,916,000 $4,833,000 -$312,000 -6.1% 01 Apr 2017 30 Jun 2017 10-K 27 Aug 2019 2019 FY
Q1 2017 $20,228,000 $5,400,000 +$1,072,000 +25% 01 Jan 2017 31 Mar 2017 10-Q 07 May 2018 2018 Q3
Q4 2016 $19,156,000 $4,952,000 +$877,000 +22% 01 Oct 2016 31 Dec 2016 10-Q 05 Feb 2018 2018 Q2
Q3 2016 $18,279,000 $4,731,000 +$620,000 +15% 01 Jul 2016 30 Sep 2016 10-Q 06 Nov 2017 2018 Q1
Q2 2016 $17,659,000 $5,145,000 +$749,000 +17% 01 Apr 2016 30 Jun 2016 10-K 27 Aug 2018 2018 FY
Q1 2016 $16,910,000 $4,328,000 +$262,000 +6.4% 01 Jan 2016 31 Mar 2016 10-Q 08 May 2017 2017 Q3
Q4 2015 $16,648,000 $4,075,000 -$48,000 -1.2% 01 Oct 2015 31 Dec 2015 10-Q 06 Feb 2017 2017 Q2
Q3 2015 $16,696,000 $4,111,000 -$117,000 -2.8% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016 2017 Q1
Q2 2015 $16,813,000 $4,396,000 -$165,000 -3.6% 01 Apr 2015 30 Jun 2015 10-K 30 Aug 2017 2017 FY
Q1 2015 $16,978,000 $4,066,000 +$146,000 +3.7% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016 2016 Q3
Q4 2014 $16,832,000 $4,123,000 +$17,000 +0.41% 01 Oct 2014 31 Dec 2014 10-Q 09 Feb 2016 2016 Q2
Q3 2014 $16,815,000 $4,228,000 +$376,000 +9.8% 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015 2016 Q1
Q2 2014 $16,439,000 $4,561,000 01 Apr 2014 30 Jun 2014 10-K 29 Aug 2016 2016 FY
Q1 2014 $3,920,000 +$140,000 +3.7% 01 Jan 2014 31 Mar 2014 10-Q/A 04 Sep 2015 2015 Q3
Q4 2013 $4,106,000 01 Oct 2013 31 Dec 2013 10-Q 10 Feb 2015 2015 Q2
Q3 2013 $3,852,000 01 Jul 2013 30 Sep 2013 10-Q 12 Nov 2014 2015 Q1
Q1 2013 $3,780,000 01 Jan 2013 31 Mar 2013 10-Q 13 May 2014 2014 Q3

PHIBRO ANIMAL HEALTH CORP Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $37,762,000 +$11,245,000 +42% 01 Jul 2024 30 Jun 2025 10-K 27 Aug 2025 2025 FY
2024 $26,517,000 +$2,201,000 +9.1% 01 Jul 2023 30 Jun 2024 10-K 27 Aug 2025 2025 FY
2023 $24,316,000 +$535,000 +2.2% 01 Jul 2022 30 Jun 2023 10-K 27 Aug 2025 2025 FY
2022 $23,781,000 +$616,000 +2.7% 01 Jul 2021 30 Jun 2022 10-K 28 Aug 2024 2024 FY
2021 $23,165,000 -$85,000 -0.37% 01 Jul 2020 30 Jun 2021 10-K 30 Aug 2023 2023 FY
2020 $23,250,000 +$1,827,000 +8.5% 01 Jul 2019 30 Jun 2020 10-K 24 Aug 2022 2022 FY
2019 $21,423,000 +$379,000 +1.8% 01 Jul 2018 30 Jun 2019 10-K 25 Aug 2021 2021 FY
2018 $21,044,000 +$1,128,000 +5.7% 01 Jul 2017 30 Jun 2018 10-K 26 Aug 2020 2020 FY
2017 $19,916,000 +$2,257,000 +13% 01 Jul 2016 30 Jun 2017 10-K 27 Aug 2019 2019 FY
2016 $17,659,000 +$846,000 +5% 01 Jul 2015 30 Jun 2016 10-K 27 Aug 2018 2018 FY
2015 $16,813,000 +$374,000 +2.3% 01 Jul 2014 30 Jun 2015 10-K 30 Aug 2017 2017 FY
2014 $16,439,000 +$1,522,000 +10% 01 Jul 2013 30 Jun 2014 10-K 29 Aug 2016 2016 FY
2013 $14,917,000 +$492,000 +3.4% 01 Jul 2012 30 Jun 2013 10-K 10 Sep 2015 2015 FY
2012 $14,425,000 01 Jul 2011 30 Jun 2012 10-K 18 Sep 2014 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.